DENTSPLY SIRONA Inc (NASDAQ:XRAY) announced a quarterly dividend on Wednesday, July 29th, RTT News reports. Shareholders of record on Friday, September 25th will be paid a dividend of 0.10 per share by the medical instruments supplier on Friday, October 9th. This represents a $0.40 dividend on an annualized basis and a yield of 0.91%.
DENTSPLY SIRONA has raised its dividend by an average of 21.0% per year over the last three years and has increased its dividend every year for the last 8 years. DENTSPLY SIRONA has a payout ratio of 28.4% meaning its dividend is sufficiently covered by earnings. Equities analysts expect DENTSPLY SIRONA to earn $2.24 per share next year, which means the company should continue to be able to cover its $0.40 annual dividend with an expected future payout ratio of 17.9%.
Shares of DENTSPLY SIRONA stock opened at $44.04 on Thursday. The company has a current ratio of 2.02, a quick ratio of 1.36 and a debt-to-equity ratio of 0.33. The business has a 50-day moving average price of $43.76 and a two-hundred day moving average price of $45.93. DENTSPLY SIRONA has a 1-year low of $31.58 and a 1-year high of $60.87. The company has a market cap of $9.65 billion, a P/E ratio of 18.20, a PEG ratio of 3.90 and a beta of 1.05.
In other news, insider William E. Newell sold 10,000 shares of the business’s stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $48.23, for a total transaction of $482,300.00. Following the completion of the transaction, the insider now directly owns 17,219 shares in the company, valued at approximately $830,472.37. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Michael C. Alfano sold 2,500 shares of the company’s stock in a transaction on Friday, May 29th. The stock was sold at an average price of $46.27, for a total transaction of $115,675.00. Following the completion of the transaction, the director now owns 15,669 shares of the company’s stock, valued at $725,004.63. The disclosure for this sale can be found here. Insiders own 0.53% of the company’s stock.
A number of equities analysts have issued reports on XRAY shares. Barrington Research downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Monday, May 11th. Robert W. Baird raised shares of DENTSPLY SIRONA from a “neutral” rating to an “outperform” rating in a research report on Sunday, April 19th. BidaskClub cut shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Thursday, July 9th. Goldman Sachs Group cut shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $58.00 to $40.00 in a research report on Tuesday, April 7th. Finally, Cfra dropped their target price on shares of DENTSPLY SIRONA from $53.00 to $38.00 and set a “hold” rating on the stock in a research report on Thursday, May 14th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $49.40.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Featured Article: How Short Selling Works
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.